banner
Pawg khoom
Tiv tauj peb

Hu rau:Errol Zhou (Mr.)

Tel: ntxiv 86-551-65523315

Mobile/WhatsApp: ntxiv 86 17705606359

QQ:196299583

Skype:lucytoday@hotmail.com

Email:sales@homesunshinepharma.com

Ntxiv:1002, Huanmao Tsev, No.105, Mengcheng Txoj kev, Hefei Lub zos, 230061 Tuam Tshoj

APIs thiab Intermediates
2- (2-N-butyl-4-hydroxy-6-methylpyrimidin-5-yl) acetic Acid CAS 1315478-16-0

2- (2-N-butyl-4-hydroxy-6-methylpyrimidin-5-yl) acetic Acid CAS 1315478-16-0

CAS TSIS TAU: 1315478-16-0


Cov Qauv Nqaij: C11H16N2O3


Cov Nqa Molecular: 224.256


EINECS TSIS MUAJ: N / A


MDL TSIS TAU: N / A

Txhawb tshuaj


Khoom Qhia:

Khoom Siv Lub Npe: 2- (2-N-butyl-4-hydroxy-6-methylpyrimidin-5-yl) acetic acid CAS TSIS: 1315478-16-0

Txhais:

2-butyl-1,6-dihydro-4-Methyl-6-oxo-5-Pyrimidineacetic acid;

Tshuaj& Cov Khoom Uas Lub Cev:

Tsos: Cov hmoov dawb dawb lossis tawm-dawb

Ntsuas: ≥99.0%

Qhov ceev: 1.24g / cm3

Lub ntsiab lus npau: 386.9 ℃ ntawm 760 mmHg

(2-Butyl-4-methyl-6-oxo-1,6-dihydro-5-pyrimidinyl) acetic acid siv rau Fimasartan nrab.

fimasartan block angiotensin II receptor type 1 (AT1 receptors), txo qis pro-hypertensive kev ua ntawm angiotensin II, xws li cov kab mob vasoconstriction thiab dej tuav cia los ntawm lub raum.

Yog tias koj txaus siab rau peb cov khoom lossis muaj lus nug, thov koj xav tiv tauj peb!

Cov khoom lag luam hauv qab patent yog muab rau R& D lub hom phiaj nkaus xwb. Txawm li cas los xij, lub luag haujlwm kawg tau txiav txim siab nrog cov neeg yuav khoom.


Cim npe nrov: 2- (2-n-butyl-4-hydroxy-6-methylpyrimidin-5-yl) acetic acid cas 1315478-16-0, tuam ntxhab, lwm tus neeg, Hoobkas, yuav, hauv Tshuag

Xa kev nug